Loading…
avatar for Stelios Tsinontides

Stelios Tsinontides

FDA, United States
Office Director, OPMA, OPQ, CDER
Dr. Stelios Tsinontides is Director of the Office of Pharmaceutical Manufacturing Assessment (OPMA). OPMA evaluates facilities, process design, and control strategies to assess capabilities of manufacturers to produce quality pharmaceutical and biotechnology products at commercial scale and provides leadership and technical expertise to Agency components internal and external to the Office of Pharmaceutical Quality regarding manufacturing quality issues.
  • Timezone
  • Filter By Date DIA 2021 Virtual Global Annual Meeting Jun 1 -Jul 1, 2021
    • June 2021
      SunMonTueWedThuFriSat
       12345
      6789101112
      13141516171819
      20212223242526
      27282930 
      July 2021
      SunMonTueWedThuFriSat
       123
      45678910
      11121314151617
      18192021222324
      25262728293031
  • Filter By Venue Virtual Meeting
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Data Standards
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClin Dev-EarlyPhaseCR
  • 07: ProjMgt-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Posters
  • 18: Networking Opportunities
  • 19: Short Courses
  • 20: Early Access Content
  • 21: InnovationTheaters
  • 22: Solution Circles
  • 23: Spotlight Symposia
  • 24: Lunch-and-Learn
  • Beginner
  • Featured Topics